Colitis ulcerative

• A Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis Recruitment ended
  2023-506994-36-00 5 2018-10-11 "Ulcerative Colitis"
• Long Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis. Recruitment ended
  2023-505699-31-00 5 2017-01-02 "Ulcerative Colitis"
• Phase 1 study on SAR443122 bioavailability and food effect in healthy adults Ended
  2025-521073-13-00 2 2025-06-11
• Testing Insulin Enemas for Ulcerative Colitis: A First-Stage Clinical Trial Ended
  2023-510335-11-00 3 2025-02-04 "Ulcerative colitis"
• Study to compare drug availability in bloodstream of two oral formulations of mesalazine in healthy volunteers under fed conditions. Ended
  2024-517107-37-00 3 2024-12-20 "Chronic idiopathic inflammatory bowel disease"
• Study to evaluate food effect on the pharmacokinetics of mesalazine oral formulation in healthy volunteers. Ended
  2024-514748-10-00 3 2024-11-28 "Ulcerative colitis"
• PARADOX study Ended
  2024-515278-28-00 6 2024-11-15 "ulcerative colitis"
• An open label, balanced, randomized, two-treatment, four period, two-sequence, multiple-dose (steady-state), fully-replicate crossover bioeq … Ended
  2024-512770-10-00 2 2024-10-07 "Rheumatoid arthritis, ulcerative colitis, atopic dermatitis,"
• A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB … Ended
  2023-507376-50-00 1 2024-09-27 "Ulcerative Colitis"
• An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci … Ended
  2024-512771-12-00 2 2024-09-17 "Axial spondyloarthritis"
• A Study to Learn How Different Amounts and Forms of the Study Intervention Called PF-07899895 are Tolerated and Act in the Body of Healthy A … Ended
  2023-507354-32-00 1 2024-09-09 "Ulcerative Colitis"
• An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci … Ended
  2024-512773-27-00 2 2024-08-19 "Rheumatoid arthritis, ulcerative colitis, atopic dermatitis,"
• PASSPORT Ended
  2023-508584-72-00 5 2024-07-10 "Immune Bowel Disease (including Crohn's disease and Ulcerati"
• A Phase 1, 2-part, open-label, single-sequence study to investigate the effect of single and multiple doses of obefazimod on the pharmacokin … Ended
  2023-509226-21-00 3 2024-06-13 "Moderately to severely active ulcerative colitis"
• A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative co … Ended
  2023-507340-36-00 3 2024-04-22 "Inflammatory bowel disease (moderate to severe active ulcera"
• A Study to Investigate Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age with Moder … Ended
  2022-502183-20-00 5 2024-02-26 "Moderately to Severely Active Ulcerative Colitis"
• A Study to Learn How Different Manufactured Products of the Study Medicine Called Ritlecitinib are Taken up Into the Blood in Healthy Adults … Ended
  2023-505603-23-00 3 2024-01-29 "ulcerative colitis, Crohn’s Disease, alopecia areata, rheuma"
• A Study to Learn About the Study Medication Called Etrasimod Mini Tablets, Including Its Taste, When Mixed With Applesauce, Chocolate Puddin … Ended
  2023-504411-32-00 3 2023-08-23 "immune-mediated inflammatory disorders, including ulcerative"
• A single-arm, open-label study to evaluate the efficacy and safety of ABBV-668 in subjectswith moderate to severe ulcerative colitis Ended
  2022-501263-41-00 4 2023-08-10 "Ulcerative Colitis"
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended
  2022-500535-36-01 5 2023-06-12 "Moderately to severely active ulcerative colitis"
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended
  2022-500536-11-01 5 2023-06-08 "Moderately to severely active ulcerative colitis"
• Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended
  2024-512558-40-00 4 2023-05-11 "Mild-to-moderate ulcerative colitis"
• Evaluating the efficacy and safety of hyperbaric oxygen therapy as an adjuvant treatment compared to biologic therapy alone in moderate to s … Ended
  2023-507450-32-00 5 "Ulcerative colitis"

Showing 25–47 of 47 trials